Share on LinkedInShare on LinkedIn

ARTICLE · 26 MARCH 2025

Sanofi Pasteur SA: An Important ECJ Ruling On Defective Paroducts

William Fry LLP
William Fry LLP
Contributor
William Fry LLP

William Fry LLP

William Fry advises leading Irish and international companies, covering both the public and private...

View firm profile
Explore more from William Fry LLP

The European Court of Justice has issued a landmark preliminary ruling in Sanofi Pasteur SA that clarifies the relationship between strict liability under the Product Liability Directive and fault-based liability claims under national law.

IrelandConsumer Protection

The preliminary ruling of the European Court of Justice (ECJ) in Sanofi Pasteur SA confirms that there are two separate bases of liability in defective product claims and that fault-based liability claims brought under national law can co-exist with strict liability claims brought under the Product Liability Directive (85/374/EEC) (PLD).

The ECJ also clarifies whether the 10‑year long‑stop under the Product Liability Directive is compatible with the right of access to a court under Article 47 of the EU Charter of Fundamental Rights, and how limitation periods should be calculated under the Product Liability Directive in progressive illness cases.

Background

On 26 March 2026, the ECJ issued its preliminary ruling in LF v Sanofi Pasteur SA (Case C‑338/24), which was referred by the Court of Appeal, Rouen, France. The referral was made in proceedings between LF (Claimant) and Sanofi Pasteur SA (a vaccine manufacturer) concerning an application for compensation for alleged harm

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from